Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Peer

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Anesthesia and Analgesia|September 1, 1995
The pharmacokinetics of alfentanil after normothermic and hypothermic cardiopulmonary bypassA Petros, N Dunne, R Mehta, et al.
Journal of Clinical Pharmacology|July 1, 1991
Pharmacokinetics of ritanserin in patients undergoing hemodialysisJ Zazgornik, J Kuska, F Kokot, et al.
Arzneimittel-Forschung|June 1, 1988
Absorption, metabolism and excretion of ketanserin in man after oral administrationW Meuldermans, J Hendrickx, R Woestenborghs, et al.
Journal of Clinical Anesthesia|November 1, 1994
Investigation of the pharmacokinetics and analgesic effects of an intramuscular injection of sustained-release sufentanil for postoperative pain: an open studyG Bergmans, B Vanacker, H Van Aken, et al.
Psychopharmacology|December 1, 1995
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in manE Snoeck, A Van Peer, M Sack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1988
Excretion and biotransformation of cisapride in dogs and humans after oral administrationW Meuldermans, A Van Peer, J Hendrickx, et al.
The Journal of Biological Chemistry|April 20, 2000
Negative growth regulation of SK-N-MC cells by bFGF defines a growth factor-sensitive point in G2V A Smits, M A van Peer, M A Essers, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulationJ W Mouton, A van Peer, K de Beule, et al.
British Journal of Clinical Pharmacology|June 1, 1990
Ketanserin pharmacokinetics in patients with renal failureJ N Barendregt, A Van Peer, J G Van Der Hoeven, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 6, 1998
Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjectsV Van de Velde, R Crabbe, A Van Peer, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Anesthesia and Analgesia|September 1, 1995
The pharmacokinetics of alfentanil after normothermic and hypothermic cardiopulmonary bypassA Petros, N Dunne, R Mehta, et al.
Journal of Clinical Pharmacology|July 1, 1991
Pharmacokinetics of ritanserin in patients undergoing hemodialysisJ Zazgornik, J Kuska, F Kokot, et al.
Arzneimittel-Forschung|June 1, 1988
Absorption, metabolism and excretion of ketanserin in man after oral administrationW Meuldermans, J Hendrickx, R Woestenborghs, et al.
Journal of Clinical Anesthesia|November 1, 1994
Investigation of the pharmacokinetics and analgesic effects of an intramuscular injection of sustained-release sufentanil for postoperative pain: an open studyG Bergmans, B Vanacker, H Van Aken, et al.
Psychopharmacology|December 1, 1995
Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in manE Snoeck, A Van Peer, M Sack, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1988
Excretion and biotransformation of cisapride in dogs and humans after oral administrationW Meuldermans, A Van Peer, J Hendrickx, et al.
The Journal of Biological Chemistry|April 20, 2000
Negative growth regulation of SK-N-MC cells by bFGF defines a growth factor-sensitive point in G2V A Smits, M A van Peer, M A Essers, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulationJ W Mouton, A van Peer, K de Beule, et al.
British Journal of Clinical Pharmacology|June 1, 1990
Ketanserin pharmacokinetics in patients with renal failureJ N Barendregt, A Van Peer, J G Van Der Hoeven, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 6, 1998
Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjectsV Van de Velde, R Crabbe, A Van Peer, et al.
Pageof 7